Showing results (191-200 of 264) with videos related to

Sort By:
Pageof 27
Radiology|October 2, 2019
Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response MarkerJessica M Winfield, Jennifer C Wakefield, David Dolling, et al.
Biomolecules|April 30, 2025
Effects of Testosterone and Its Major Metabolites upon Different Stages of Neuron Survival in the Dentate Gyrus of Male RatsMark D Spritzer, Ethan A Roy, Kelsey M K Calhoun, et al.
European Urology|March 4, 2018
Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)Niven Mehra, David Dolling, Semini Sumanasuriya, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 23, 2016
Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patientsChristian Nicolaj Andreassen, Barry S Rosenstein, Sarah L Kerns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetateAlison H M Reid, Gerhardt Attard, Daniel C Danila, et al.
BMJ Open|January 1, 2021
Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidanceShaista Hafeez, Amanda Webster, Vibeke N Hansen, et al.
BMC Cancer|October 8, 2016
DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancerImran Petkar, Keith Rooney, Justin W G Roe, et al.
JNCI Cancer Spectrum|October 3, 2023
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess responseChris Parker, Nina Tunariu, Holly Tovey, et al.
Nature Cancer|July 12, 2024
Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancerJavier Fernandez-Mateos, George D Cresswell, Nicholas Trahearn, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2018
The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP TrialJames M Wilson, David P Dearnaley, Isabel Syndikus, et al.
Pageof 27